Form EFFECT Clearmind Medicine Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 22, 2024 |
| Accession Number: | 0001213900-24-024410 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clearmind patent application for dyskinesia treatment published in Japan
- Superior Shower Doors Debuts High-End Frameless Installations in Bergen County
- Ripple News: Nasdaq Opens a New Door for XRP as Remittix Builds Its Consumer Payments Ecosystem
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share